...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease.
【24h】

Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease.

机译:Rac GTPases,PKC和血浆细胞因子调节的红细胞NADPH氧化酶活性有助于镰状细胞疾病的氧化应激。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Chronic inflammation has emerged as an important pathogenic mechanism in sickle cell disease (SCD). One component of this inflammatory response is oxidant stress mediated by reactive oxygen species (ROS) generated by leukocytes, endothelial cells, plasma enzymes, and sickle red blood cells (RBC). Sickle RBC ROS generation has been attributed to sickle hemoglobin auto-oxidation and Fenton chemistry reactions catalyzed by denatured heme moieties bound to the RBC membrane. In this study, we demonstrate that a significant part of ROS production in sickle cells is mediated enzymatically by NADPH oxidase, which is regulated by protein kinase C, Rac GTPase, and intracellular Ca(2+) signaling within the sickle RBC. Moreover, plasma from patients with SCD and isolated cytokines, such as transforming growth factor β1 and endothelin-1, enhance RBC NADPH oxidase activity and increase ROS generation. ROS-mediated damage to RBC membrane components is known to contribute to erythrocyte rigidity and fragility in SCD. Erythrocyte ROS generation, hemolysis, vaso-occlusion, and the inflammatory response to tissue damage may therefore act in a positive-feedback loop to drive the pathophysiology of sickle cell disease. These findings suggest a novel pathogenic mechanism in SCD and may offer new therapeutic targets to counteract inflammation and RBC rigidity and fragility in SCD.
机译:慢性炎症已成为镰状细胞疾病(SCD)的重要致病机制。这种炎症反应的一个组成部分是由白细胞,内皮细胞,血浆酶和镰状红细胞(RBC)产生的活性氧(ROS)介导的氧化应激。镰状红细胞ROS的产生已归因于镰刀血红蛋白的自氧化作用和结合到RBC膜上的变性血红素部分催化的芬顿化学反应。在这项研究中,我们证明了镰状细胞中ROS产生的很大一部分是由NADPH氧化酶酶促介导的,NADPH氧化酶由镰状RBC中的蛋白激酶C,Rac GTPase和细胞内Ca(2+)信号传导调节。此外,来自患有SCD和分离的细胞因子(例如转化生长因子β1和内皮素-1)的患者的血浆可增强RBC NADPH氧化酶活性并增加ROS的产生。已知ROS介导的对RBC膜成分的损害会导致SCD中的红细胞刚性和脆性。因此,红细胞ROS的产生,溶血,血管闭塞以及对组织损伤的炎性反应可能会在正反馈回路中起作用,从而驱动镰状细胞病的病理生理。这些发现提示SCD中存在新的致病机制,并可能提供新的治疗靶标以抵消SCD中的炎症以及RBC的刚性和脆弱性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号